NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing

NACompletedINTERVENTIONAL
Enrollment

645

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

March 1, 2017

Study Completion Date

March 1, 2017

Conditions
CancerCardiovascular DiseaseNeurologic DysfunctionCongenital AbnormalitiesHearing Loss
Interventions
BEHAVIORAL

Experimental

Option to request non-medically actionable incidental information (after receiving education about them)

Trial Locations (1)

27599

University of North Carolina at Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

National Human Genome Research Institute (NHGRI)

NIH

collaborator

UNC Lineberger Comprehensive Cancer Center

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT01969370 - NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing | Biotech Hunter | Biotech Hunter